Total Payments
$993,222
2024 Payments
$112,672
Companies
37
Transactions
1,940
Medicare Patients
757
Medicare Billing
$76,176
Payment Breakdown by Category
Other$699,279 (70.4%)
Consulting$151,902 (15.3%)
Travel$95,567 (9.6%)
Food & Beverage$39,514 (4.0%)
Research$6,900 (0.7%)
Education$59.30 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $504,736 | 290 | 50.8% |
| Honoraria | $189,593 | 83 | 19.1% |
| Consulting Fee | $151,902 | 58 | 15.3% |
| Travel and Lodging | $95,567 | 690 | 9.6% |
| Food and Beverage | $39,514 | 813 | 4.0% |
| Unspecified | $6,900 | 3 | 0.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,950 | 2 | 0.5% |
| Education | $59.30 | 1 | 0.0% |
Payments by Type
General
$986,322
1,937 transactions
Research
$6,900
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $310,972 | 611 | $0 (2024) |
| EISAI INC. | $156,576 | 255 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $154,641 | 396 | $0 (2022) |
| SK Life Science, Inc. | $141,190 | 194 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $53,140 | 43 | $0 (2024) |
| Lundbeck LLC | $34,757 | 73 | $0 (2021) |
| Neurelis, Inc. | $26,051 | 35 | $0 (2024) |
| Greenwich Biosciences, Inc. | $23,656 | 32 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $21,101 | 33 | $0 (2024) |
| UCB SA | $20,771 | 28 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $112,672 | 150 | CATALYST PHARMACEUTICALS, INC. ($38,872) |
| 2023 | $74,290 | 138 | SK Life Science, Inc. ($24,747) |
| 2022 | $90,486 | 195 | UCB, Inc. ($42,707) |
| 2021 | $71,509 | 126 | SK Life Science, Inc. ($55,212) |
| 2020 | $83,375 | 115 | UCB, Inc. ($24,064) |
| 2019 | $118,282 | 239 | UCB, Inc. ($32,976) |
| 2018 | $184,471 | 434 | Sunovion Pharmaceuticals Inc. ($59,411) |
| 2017 | $258,137 | 543 | UCB, Inc. ($106,648) |
All Payment Transactions
1,940 individual payment records from CMS Open Payments — Page 1 of 78
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,036.00 | General |
| Category: EPILEPSY | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,024.00 | General |
| Category: EPILEPSY | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,024.00 | General |
| Category: EPILEPSY | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,024.00 | General |
| Category: EPILEPSY | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | Cash or cash equivalent | $33.50 | General |
| Category: EPILEPSY | ||||||
| 12/18/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $50.84 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | In-kind items and services | $293.69 | General |
| Category: EPILEPSY | ||||||
| 12/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $105.77 | General |
| Category: EPILEPSY | ||||||
| 12/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $106.18 | General |
| 12/08/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $199.67 | General |
| 12/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $71.11 | General |
| 12/07/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $125.55 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $134.98 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Neurology | ||||||
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $139.22 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $121.57 | General |
| Category: EPILEPSY | ||||||
| 11/26/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Honoraria | Cash or cash equivalent | $6,160.00 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Travel and Lodging | Cash or cash equivalent | $109.95 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $8.99 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | Neurelis, Inc. | VALTOCO (Drug) | Travel and Lodging | In-kind items and services | $459.95 | General |
| Category: EPILEPSY | ||||||
| 11/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $88.15 | General |
| Category: EPILEPSY | ||||||
| 11/20/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $101.48 | General |
| Category: Neurology | ||||||
| 11/18/2024 | SK Life Science, Inc. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A systematic review of the burden of disease and rescue medication treatment patterns in seizure clusters | UCB, Inc. | $6,900 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 223 | 274 | $69,589 | $20,612 |
| 2022 | 7 | 188 | 246 | $61,865 | $18,357 |
| 2021 | 7 | 161 | 205 | $54,664 | $16,590 |
| 2020 | 7 | 185 | 248 | $83,451 | $20,617 |
Total Patients
757
Total Services
973
Medicare Billing
$76,176
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 32 | 70 | $37,310 | $10,847 | 29.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 77 | 77 | $11,396 | $2,912 | 25.6% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 22 | 22 | $7,568 | $2,237 | 29.6% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 37 | 40 | $5,960 | $1,599 | 26.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 16 | $2,144 | $1,203 | 56.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 27 | 27 | $4,023 | $1,184 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 22 | $1,188 | $630.10 | 53.0% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 25 | 63 | $33,579 | $9,626 | 28.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 50 | 51 | $7,548 | $2,209 | 29.3% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 19 | 19 | $6,536 | $1,928 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 24 | $3,216 | $1,391 | 43.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 26 | 27 | $4,978 | $1,187 | 23.8% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 27 | 28 | $4,172 | $1,079 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 25 | 34 | $1,836 | $935.29 | 50.9% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 28 | 57 | $30,381 | $8,873 | 29.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 40 | 40 | $5,920 | $1,703 | 28.8% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 14 | 16 | $5,504 | $1,700 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 20 | 26 | $3,952 | $1,689 | 42.7% |
| 95822 | Measurement and recording of brain wave (eeg) activity, in coma or asleep | Facility | 2021 | 26 | 27 | $4,023 | $1,228 | 30.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 21 | 27 | $3,096 | $888.78 | 28.7% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 12 | 12 | $1,788 | $508.98 | 28.5% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 30 | 78 | $41,574 | $12,374 | 29.8% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 47 | 49 | $15,072 | $2,261 | 15.0% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 17 | 21 | $7,224 | $2,254 | 31.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 32 | 40 | $4,500 | $1,192 | 26.5% |
About Dr. Steve Chung, M.D
Dr. Steve Chung, M.D is a Neurology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942317359.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steve Chung, M.D has received a total of $993,222 in payments from pharmaceutical and medical device companies, with $112,672 received in 2024. These payments were reported across 1,940 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($504,736).
As a Medicare-enrolled provider, Chung has provided services to 757 Medicare beneficiaries, totaling 973 services with total Medicare billing of $76,176. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Phoenix, AZ
- Active Since 08/23/2006
- Last Updated 12/16/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1942317359
Products in Payments
- Briviact (Drug) $199,802
- APTIOM (Drug) $148,600
- Fycompa (Drug) $142,825
- XCOPRI (Drug) $119,785
- Nayzilam (Drug) $53,518
- FYCOMPA (Drug) $53,063
- ONFI (Drug) $34,719
- VALTOCO (Drug) $26,051
- Epidiolex (Drug) $23,656
- Vimpat (Drug) $22,953
- EPIDIOLEX (Drug) $21,101
- Cenobamate (Drug) $17,544
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $15,576
- Banzel (Drug) $13,690
- SYMPAZAN (Drug) $10,767
- Fintepla (Drug) $8,560
- Aptiom (Drug) $5,373
- ACTIVA (Device) $1,890
- Neuroblate (Device) $1,855
- RNS System (Device) $1,538
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Phoenix
Barry Hendin, Md, MD
Neurology — Payments: $3.0M
Neurology $3.0M
Maria Ospina, Md, MD
Neurology — Payments: $1.7M
Neurology $1.7M
Dr. Suraj Muley, Md, MD
Neurology — Payments: $1.5M
Neurology $1.5M
Shafeeq Ladha, M.d, M.D
Neurology — Payments: $712,796
Neurology $712,796
Lori Travis, Md, MD
Neurology — Payments: $705,788
Neurology $705,788
Dr. Jeffrey Gitt, D.o, D.O
Neurology — Payments: $669,966
Neurology $669,966